Source: Vampire Program: CENTCOM Clinical Operations Protocol-01: Urgent Resuscitation using Blood Products during Tactical Evacuation from Point of Injury Show PURPOSE To provide essential instructions on urgent/life-saving resuscitation procedures using blood products during tactical evacuation (refers to both casualty evacuation and medical evacuation) from the point of injury (POI) for casualties suffering major blood loss/massive hemorrhage. Referred to as the Vampire Program. This guideline supports the Joint Trauma System (JTS) Damage Control Resuscitation Clinical Practice Guideline (CPG), Whole Blood Transfusion CPG, and the Tactical Combat Casualty Care (TCCC) Guidelines. Guidance applies to medical and non-medical personnel (e.g., flight medic, crew chief, registered nurse, enlisted medical personnel, physician, nurse practitioner, or, physician assistant), assigned/attached or allocated to perform tactical medical response (TCCC) and evacuation (CASEVAC and MEDEVAC) duties that involve direct or indirect patient care. FIELD INDICATIONS FOR TRANSFUSION DURING TACTICAL EVACUATION The following are indications for transfusion in the presence of severe traumatic injury:
WARNING: The amputation patterns above are the only traumatic injuries that constitute a stand-alone immediate field indicator for transfusion that requires no confirmation with vital sign parameters. CAUTION: Control external bleeding before or simultaneously with initiation of blood product transfusion. Traumatic Arrest: patient with exsanguination who had signs of life when received from ground forces and has since become pulseless should receive immediate transfusion (transfusion is more important than chest compressions in cases of exsanguination and should take priority). Traumatic injuries where early blood transfusions are most likely to be needed:
Initiate transfusion with 1 unit of blood product. Give additional units if clinically indicated. Avoid resuscitation with crystalloid which may increase bleeding, particularly from non-compressible torso hemorrhage. Refer to Appendix C for list of clinical indicators for hemorrhagic shock. PROCEDURE Blood Component Therapy Approved for Transfusion during Tactical Evacuation Red blood cells (RBCs) increase the recipient’s oxygen-carrying capacity by increasing the mass of circulating red cells. Plasma and platelets work together to improve blood clot formation and clot stability. On average a unit of whole blood (WB) contains a volume of 500-600 mL and a unit of RBC’s contains a volume of 300-400 mL. In an exsanguinating patient, a unit of blood can be given quickly. Ensure good blood flow through IV or IO access before initiating transfusion. Refer to Appendix D for Transfusion Procedures and Appendix F for Pearls for Transfusion. CAUTION: Rapid infusion against resistance can cause mechanical shearing of RBCs and should be avoided. 1. Blood products will be administered in the following priority depending on availability and according to TCCC Guidelines:
NOTE: LTOWB has been screened for anti-A and anti-B antibodies; these units contained a low titer of anti-A and anti-B and are therefore considered a universal donor product that may be given to recipients of any blood type with a minimum risk for a minor ABO incompatibility (typically minor and most often subclinical clinical consequences). The whole blood supplied to MEDEVAC units will be exclusively drawn in the United States from the ASBP-approved sites and distributed in theater by the ASBP blood distribution system. The LTOWB units will be fully tested following FDA current guidelines. 2. POS (either low titer Group O WB or Type O RBCs) is the standard for transfusion during evacuation. NOTE: Patients requiring blood can safely receive un-cross matched low titer Group O WB or Type O RBCs until type-specific products are available. 3. If available, use O NEG on females of childbearing potential age <50 years old. Inform receiving facility regarding female given O POS blood for documentation in the medical record. If a minimal amount (just a few milliliters) is given, consider Rhogam therapy. The immunologic consequences of administration of an entire unit of O POS whole blood or RBC to an O NEG female of child-bearing potential cannot safely be reversed with Rhogam. Treatment of exsanguination takes precedence over potential future pregnancy outcomes. CAUTION: WB collected in theater will NOT be supplied for use onboard MEDEVAC aircraft. Plasma is recognized as an important component in preventing and treating coagulopathy in trauma. On average a unit contains a volume of 200-250 mL and is transfused rapidly.
The recommended mission loads for tactical evacuation are based on operations tempo and determined by the theater or Joint Task Force surgeon. Specific missions may require additional blood products; units will refer to the Joint Blood Program Office.
Pediatric patients:
Receiving Blood Components from an Issuing Facility (U.S. and Coalition) U.S. issuing facility personnel from the Blood Support Detachment (BSD), MTF (Role 2/3) or lab will:
Non-U.S. Issuing Facility: When U.S. blood products are to be issued from a Coalition facility, contact the Joint Blood Program Office to coordinate issuing requirements and documentation of units received. Receiving unit (Evacuation Unit) personnel will:
Storage, Transportation and Monitoring of Blood Products
WARNINGS: - At no time will container or its contents (blood products) be placed in a refrigerator or other cooling device outside a blood bank. - Blood products will not be used if container is leaking; or the temperature indicator (Safe-T-VUE) on the blood product is out of standard (refer to Appendix E). - Notify the issuing facility and return container and products for replacement. Individual and Unit Training Requirements
Essential Items Required for Implementing a Vampire Program
Warming Devices for Blood Transfusion Use of infusion warming devices is highly recommended. These will be FDA approved for the actual use in transfusion of blood products (examples of devices include: Belmont® Buddy-lite™, EnFlow® or Thermal Angel). WARNING: Warming devices will have safety mechanisms built in that prevents the output temperature from exceeding 42°C. Unit personnel will be familiar with safety mechanisms for the device used. Tranexamic Acid (TXA) Patients receiving blood transfusion within three hours of injury should also receive TXA. Refer to the TCCC guidelines for administration of TXA. Record Keeping and Documentation Requirements
References
What is the term for administration of fluids medications or nutrients through the IV route?Intravenous therapy (abbreviated as IV therapy) is a medical technique that administers fluids, medications and nutrients directly into a person's vein.
What is the route of administration for IV?An intravenous route directly administers the medications to the systemic circulation. It is indicated when a rapid drug effect is desired, a precise serum drug level is needed, or when drugs are unstable or poorly absorbed in the gastrointestinal tract.
What is route of administration of drugs?A route of administration in pharmacology and toxicology is the way by which a drug, fluid, poison, or other substance is taken into the body.
What is an IV medication?Intravenous means "within a vein." Most often it refers to giving medicines or fluids through a needle or tube inserted into a vein. This allows the medicine or fluid to enter your bloodstream right away.
|